Physiological Intermolecular Modification Spectroscopy for the Prediction of Response to Anti-Tumor Necrosis Factor Therapy in Patients with Inflammatory Bowel Diseases

Publisher： Karger

E-ISSN： 1421-9875|32|4|446-454

ISSN： 0257-2753

Source： Digestive Diseases, Vol.32, Iss.4, 2014-06, pp. : 446-454

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Patient’s Perspectives Important for Early Anti-Tumor Necrosis Factor Treatment in Inflammatory Bowel Disease

By  

Digestion, Vol. 79, Iss. 1, 2009-02 ,pp. : 30-35

Karger

Access to resources Recommend Favorite

The long-term outcome of anti-tumor necrosis factor-α therapy related to fecal calprotectin values during induction therapy in pediatric inflammatory bowel disease

By Kolho Kaija-Leena   Sipponen Taina  

Scandinavian Journal of Gastroenterology, Vol. 49, Iss. 4, 2014-04 ,pp. : 434-441

Informa Healthcare

Access to resources Recommend Favorite

Specific Biologic Therapy with Tumor Necrosis Factor Inhibitors in Patients with Inflammatory Myopathy

By  

Current Rheumatology Reviews, Vol. 1, Iss. 2, 2005-06 ,pp. : 157-165

Bentham Science Publishers

Access to resources Recommend Favorite

Anti-Tumor Necrosis Factor-amp;#945; Therapy in Undifferentiated Spondyloarthritis (USpA)

By  

Current Rheumatology Reviews, Vol. 5, Iss. 3, 2009-08 ,pp. : 174-176

Bentham Science Publishers

Access to resources Recommend Favorite

Beyond Tumor Necrosis Factor: Next-Generation Biologic Therapy for Inflammatory Bowel Disease

By  

Digestive Diseases, Vol. 27, Iss. 3, 2009-09 ,pp. : 366-369

Karger

Access to resources Recommend Favorite